ArticleJournal of physiology and biochemistry2024
The SGLT2 inhibitor empagliflozin attenuates atherosclerosis progression by inducing autophagy.
Hualin Xu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it